Poseida Therapeutics, Inc. (PSTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 3.0500 |
| Open | 3.0900 |
| Bid | 3.1200 x 800 |
| Ask | 3.1300 x 800 |
| Day's range | 3.0000 - 3.2498 |
| 52-week range | 1.5400 - 8.8200 |
| Volume | |
| Avg. volume | 493,871 |
| Market cap | 302.173M |
| Beta (5Y monthly) | 0.25 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.5400 |
| Earnings date | 07 Mar 2024 - 11 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.25 |
PR NewswirePoseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2023
Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced updates and financial results for the third quarter ended September 30, 2023.
- PR Newswire
Poseida Therapeutics to Present at Two Upcoming Investor Conferences
Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced that the Company will participate in the following upcoming investor conferences in November:
ZacksPoseida Therapeutics, Inc. (PSTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Poseida Therapeutics, Inc. (PSTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2023 Yahoo. All rights reserved.